Business ❯ Healthcare

Pharmaceutical Industry

Drug Development Drug Pricing Market Trends Drug Manufacturers Market Analysis Manufacturing Market Competition Drug Manufacturing Biotechnology Clinical Trials

Wall Street Unanimously Bullish on Teva as Austedo Fuels Turnaround

Analysts say rising Austedo sales alongside Teva's move into branded drugs could lift the stock if the company sustains execution.

Stories older than 24h

Johnson & Johnson Beats Q2 Estimates and Lifts Full‑Year Outlook

Brazil Seeks Semaglutide Access for SUS After New Price Offer and Government Pilot

FTC Clears Aurobindo's $250 Million Purchase of Lannett

Pfizer CFO Dave Denton to Exit and Cecile Guegan Named Interim

Veeva Beats Q1 Estimates and Raises Outlook as It Pushes an AI Pivot

Pacira Presses Shareholders to Back Its Board in Active Proxy Fight

Mexico Seeks Role as Latin America Clinical-Trial Hub With New Funding and AI

Jury Finds Takeda Liable for Delaying Amitiza Generics, Awards $885 Million

Analysts Lift Eli Lilly Targets After Blowout Quarter and Foundayo Debut

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

Sun Pharma to Buy Organon for $11.75 Billion in All-Cash Deal

Ligand to Buy XOMA Royalty for $739 Million

Sun Pharma Said to Make $13 Billion All-Cash Offer for Organon

Inaugural Hurun 'Successors 50' Shows Next-Gen Leaders Drove 6.7x Value Surge Since 2020

CVS Advances Settlement in FTC Insulin Case Seen as Lifting Market Overhang

Structure’s Oral Obesity Pill Delivers 16.3% Placebo-Adjusted Weight Loss in Phase 2

Trump Touts MFN Drug Deals, Urges GOP to Codify Policy at Doral Retreat

Xenon to Present Topline X-TOLE2 Phase 3 Results in Focal Onset Seizures at 8 A.M. ET Today

Servier to Acquire Day One Biopharma in $2.5 Billion All-Cash Deal at $21.50 a Share